Published in Ocul Immunol Inflamm on June 01, 2004
Eye disorders in patients with multiple sclerosis: natural history and management. Clin Ophthalmol (2010) 1.10
Common genetic determinants of uveitis shared with other autoimmune disorders. J Immunol (2008) 0.92
Ischemic retinal vasculitis and its management. J Ophthalmol (2014) 0.86
Uveitis and neurologic diseases: an often overlooked relationship. Wien Klin Wochenschr (2006) 0.86
Clinical characteristics of intermediate uveitis in Tunisian patients. Int Ophthalmol (2010) 0.85
Pharmacotherapy for uveitis: current management and emerging therapy. Clin Ophthalmol (2014) 0.81
Gender and uveitis in patients with multiple sclerosis. J Ophthalmol (2014) 0.78
Vitreous diagnosis in neoplastic diseases. Mediators Inflamm (2012) 0.77
Analysis of a Functional IL-6 Gene Polymorphism in HLAB27 Associated and Intermediate Uveitis Gives New Insight in Disease Pathogenesis and Commonality with Other Autoimmune Diseases. J Immunol Res (2015) 0.77
Intermediate uveitis: pattern of etiology, complications, treatment and outcome in a tertiary academic center. Orphanet J Rare Dis (2017) 0.75
Gender disparities in ocular inflammatory disorders. Curr Eye Res (2014) 0.75
Uveitis associated with multiple sclerosis: complications and visual prognosis. Int J Ophthalmol (2014) 0.75
Associations of Independent IL2RA Gene Variants with Intermediate Uveitis. PLoS One (2015) 0.75
The role of sex in uveitis and ocular inflammation. Int Ophthalmol Clin (2015) 0.75
Unusual presentation of a multiple sclerosis case involving central retinal artery occlusion. Saudi J Ophthalmol (2014) 0.75
The approach to bilateral simultaneous isolated optic neuritis. Br J Ophthalmol (2006) 0.75
Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis. Sci Transl Med (2010) 4.95
Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis. Arch Ophthalmol (2011) 3.63
Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study. BMJ (2009) 2.23
Plasmapheresis for lupus retinal vasculitis. Arch Ophthalmol (2006) 2.13
The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. Arch Dermatol (2002) 2.10
Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature. Ann Allergy Asthma Immunol (2005) 2.01
Methods for identifying long-term adverse effects of treatment in patients with eye diseases: the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study. Ophthalmic Epidemiol (2008) 1.87
Clinical characteristics of a large cohort of patients with scleritis and episcleritis. Ophthalmology (2011) 1.85
Cyclosporine for ocular inflammatory diseases. Ophthalmology (2010) 1.75
Evaluation of tear osmolarity in non-Sjögren and Sjögren syndrome dry eye patients with the TearLab system. Cornea (2012) 1.74
Analysis of pediatric uveitis cases at a tertiary referral center. Ophthalmology (2005) 1.69
Relapsing polychondritis: a clinical review. Semin Arthritis Rheum (2002) 1.68
Reliability and repeatability of swept-source Fourier-domain optical coherence tomography and Scheimpflug imaging in keratoconus. J Cataract Refract Surg (2012) 1.68
Intravitreal bevacizumab for treatment of uveitic macular edema. Ophthalmology (2007) 1.66
Nonsteroidal anti-inflammatory therapy and recurrent acute anterior uveitis. Ocul Immunol Inflamm (2010) 1.62
Adverse effects of smoking on patients with ocular inflammation. Br J Ophthalmol (2010) 1.61
Methotrexate for ocular inflammatory diseases. Ophthalmology (2009) 1.58
Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidence. Am J Ophthalmol (2008) 1.56
Ocular pemphigus. J Am Acad Dermatol (2005) 1.56
Activation of neural progenitor cells in human eyes with proliferative vitreoretinopathy. Exp Eye Res (2012) 1.46
Azathioprine for ocular inflammatory diseases. Am J Ophthalmol (2009) 1.44
Mycophenolate mofetil for ocular inflammation. Am J Ophthalmol (2009) 1.41
Punctate inner choroidopathy: a survey analysis of 77 persons. Ophthalmology (2007) 1.36
Two-year safety and efficacy of ranibizumab 0.5 mg in diabetic macular edema: interim analysis of the RESTORE extension study. Ophthalmology (2013) 1.33
Etiology and management of idiopathic orbital inflammation. Am J Ophthalmol (2004) 1.33
Initial evaluation of subcutaneous daclizumab treatments for noninfectious uveitis: a multicenter noncomparative interventional case series. Ophthalmology (2005) 1.33
Molecular mechanisms of retinal pigment epithelium damage and development of age-related macular degeneration. Acta Ophthalmol (2011) 1.31
Vogt-Koyanagi-Harada disease. Int Ophthalmol Clin (2006) 1.25
Ocular inflammation in Behçet disease: incidence of ocular complications and of loss of visual acuity. Am J Ophthalmol (2008) 1.23
Ocular cicatricial pemphigoid: pathogenesis, diagnosis and treatment. Prog Retin Eye Res (2004) 1.20
Multifocal choroiditis and panuveitis: immunomodulatory therapy. Ophthalmology (2002) 1.20
Primary intraocular lymphoma: A review. Semin Ophthalmol (2006) 1.19
Acute posterior multifocal placoid pigment epitheliopathy: outcome and visual prognosis. Retina (2009) 1.19
360 degrees iris-ciliary body B-cell lymphoma masquerading as post-cataract uveitis. Semin Ophthalmol (2004) 1.18
High-dose methotrexate for intraocular lymphoma. Clin Cancer Res (2003) 1.15
Cyclophosphamide for ocular inflammatory diseases. Ophthalmology (2009) 1.14
Role of collagen-binding heat shock protein 47 and transforming growth factor-beta1 in conjunctival scarring in ocular cicatricial pemphigoid. Invest Ophthalmol Vis Sci (2003) 1.14
Glaucoma and uveitis. Surv Ophthalmol (2012) 1.13
Long-term results of Ahmed glaucoma valve implantation for uveitic glaucoma. Am J Ophthalmol (2007) 1.12
Intravitreal clindamycin for toxoplasmic retinochoroiditis. Retina (2007) 1.11
Anterior segment optical coherence tomography. Semin Ophthalmol (2010) 1.09
Biologic response modifier therapy for psoriatic ocular inflammatory disease. Ocul Immunol Inflamm (2008) 1.09
Strong associations between specific HLA-DQ and HLA-DR alleles and the tubulointerstitial nephritis and uveitis syndrome. Invest Ophthalmol Vis Sci (2003) 1.08
Long-term follow-up of patients with birdshot retinochoroidopathy treated with corticosteroid-sparing systemic immunomodulatory therapy. Ophthalmology (2005) 1.08
Mycophenolate mofetil as an immunomodulatory agent in the treatment of chronic ocular inflammatory disorders. Ophthalmology (2003) 1.07
Scleritis therapy. Ophthalmology (2011) 1.07
Limbal stem cell transplantation in chronic inflammatory eye disease. Ophthalmology (2002) 1.07
Visual outcomes in children with juvenile idiopathic arthritis-associated uveitis. Ophthalmology (2006) 1.07
Clinical review: treatment of vitreoretinal lymphoma. Ocul Immunol Inflamm (2009) 1.06
Bilateral uveitis associated with fluoroquinolone therapy. Cutan Ocul Toxicol (2011) 1.05
Vogt-Koyanagi-Harada syndrome associated with bilateral serous macular detachments responsive to immunomodulatory therapy. Ophthalmic Surg Lasers Imaging (2009) 1.05
Sterile corneal melting and necrotizing scleritis after cataract surgery in patients with rheumatoid arthritis and collagen vascular disease. Semin Ophthalmol (2003) 1.04
The Boston keratoprosthesis in Stevens-Johnson syndrome. Am J Ophthalmol (2008) 1.04
Risk of hypotony in noninfectious uveitis. Ophthalmology (2012) 1.03
The spectrum of fundus autofluorescence findings in birdshot chorioretinopathy. J Ophthalmol (2010) 1.02
Risk of choroidal neovascularization among the uveitides. Am J Ophthalmol (2013) 1.02
Apoptotic response of uveal melanoma cells upon treatment with chelidonine, sanguinarine and chelerythrine. Cancer Lett (2005) 1.02
Subconjunctival bevacizumab for corneal neovascularization. Cornea (2008) 1.02
Infliximab therapy for the treatment of refractory ocular inflammatory disease. Arch Ophthalmol (2007) 1.01
Mycophenolate mofetil after methotrexate failure or intolerance in the treatment of scleritis and uveitis. Ophthalmology (2008) 1.01
Ocular manifestations and concepts of systemic vasculitides. Surv Ophthalmol (2004) 1.01
The cell-layer- and cell-type-specific distribution of GalNAc-transferases in the ocular surface epithelia is altered during keratinization. Invest Ophthalmol Vis Sci (2003) 1.01
Infliximab for the treatment of refractory scleritis. Br J Ophthalmol (2009) 1.01
Visual outcome in herpes simplex virus and varicella zoster virus uveitis: a clinical evaluation and comparison. Ophthalmology (2002) 1.00
Cancer associated retinopathy (CAR): An autoimmune-mediated paraneoplastic syndrome. Semin Ophthalmol (2006) 1.00
Hypopyon in patients with uveitis. Ophthalmology (2009) 0.99
Elevated levels of interleukin 6 in the vitreous fluid of patients with pars planitis and posterior uveitis: the Massachusetts eye & ear experience and review of previous studies. Ocul Immunol Inflamm (2004) 0.99
Anterior segment changes with age and during accommodation measured with partial coherence interferometry. J Cataract Refract Surg (2007) 0.98
Scleral necrosis in a patient with congenital erythropoietic porphyria. Cornea (2011) 0.98
Risk factors for loss of visual acuity among patients with uveitis associated with juvenile idiopathic arthritis: the Systemic Immunosuppressive Therapy for Eye Diseases Study. Ophthalmology (2012) 0.97
Biological response modifier therapy for refractory childhood uveitis. Br J Ophthalmol (2007) 0.97
Successful treatment of idiopathic orbital inflammation with mycophenolate mofetil. Am J Ophthalmol (2005) 0.97
Long-term progression, prognosis, and treatment of patients with recurrent ocular manifestations of Reiter's syndrome. Ophthalmology (2003) 0.96
Pterygia: pathogenesis and the role of subconjunctival bevacizumab in treatment. Semin Ophthalmol (2009) 0.96
Mycophenolate mofetil and fundus autofluorescence in the management of recurrent punctate inner choroidopathy. Ocul Immunol Inflamm (2011) 0.96
Chronic postoperative endophthalmitis due to pseudomonas oryzihabitans. Am J Ophthalmol (2002) 0.96
Assessment of corneal topography indices after collagen crosslinking for keratoconus. Eur J Ophthalmol (2013) 0.96
Systemic therapy with conventional and novel immunomodulatory agents for ocular inflammatory disease. Surv Ophthalmol (2011) 0.96
Treatment of ocular inflammatory disorders with daclizumab. Ophthalmology (2003) 0.96
Ocular disease in patients with ANCA-positive vasculitis. J Ocul Biol Dis Infor (2009) 0.95
Combined pars plana vitrectomy and phacoemulsification to restore visual acuity in patients with chronic uveitis. J Cataract Refract Surg (2005) 0.94
Discoid lupus erythematosus masquerading as chronic blepharoconjunctivitis. Ophthalmology (2005) 0.93
A comparison between the fluocinolone acetonide (Retisert) and dexamethasone (Ozurdex) intravitreal implants in uveitis. J Ocul Pharmacol Ther (2013) 0.93
Multifocal nodular episcleritis and scleritis with undiagnosed Hodgkin's lymphoma. Ophthalmology (2003) 0.93
Ocular characteristics and disease associations in scleritis-associated peripheral keratopathy. Arch Ophthalmol (2002) 0.93
Keratometry evaluations with the Pentacam high resolution in comparison with the automated keratometry and conventional corneal topography. Cornea (2012) 0.92
Solitary myofibroma of the sclera. Cornea (2007) 0.92
Difluprednate 0.05% versus prednisolone acetate 1% for endogenous anterior uveitis: a phase III, multicenter, randomized study. Invest Ophthalmol Vis Sci (2014) 0.92
Mucous membrane pemphigoid: an update. Curr Opin Ophthalmol (2005) 0.92
Clinical features and presentation of infectious scleritis from herpes viruses: a report of 35 cases. Ophthalmology (2012) 0.92
Ocular and extracutaneous involvement in pyoderma gangrenosum. Ophthalmology (2002) 0.92
Mooren ulcer: an immunopathologic study. Cornea (2006) 0.91
Mycophenolate mofetil therapy for sarcoidosis-associated uveitis. Ocul Immunol Inflamm (2009) 0.91
Cytomegalovirus retinitis in immunocompetent patients: case reports and literature review. Ocul Immunol Inflamm (2013) 0.91
Role of connective tissue growth factor in the pathogenesis of conjunctival scarring in ocular cicatricial pemphigoid. Invest Ophthalmol Vis Sci (2003) 0.91
Systemic immunomodulatory therapy in severe dry eye secondary to inflammation. Ocul Immunol Inflamm (2007) 0.91
Electroretinograms as an indicator of disease activity in birdshot retinochoroidopathy. Graefes Arch Clin Exp Ophthalmol (2002) 0.91
Analysis of clonal immunoglobulin heavy chain rearrangements in ocular lymphoma. Cancer (2005) 0.90
Response of pediatric uveitis to tumor necrosis factor-α inhibitors. J Rheumatol (2013) 0.90
Pseudophakic accommodation and pseudoaccommodation under physiological conditions measured with partial coherence interferometry. J Cataract Refract Surg (2006) 0.89